CD4+ Th0 cell clones, isolated from a metastatic lymph node of a melanoma patient, possess cytolytic function

[1]  P. Kourilsky,et al.  Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. , 1994, Journal of immunology.

[2]  S. Rosenberg,et al.  T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Parmiani,et al.  Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cells. , 1993, Immunology today.

[4]  J. Richie,et al.  CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells. , 1993, Cellular immunology.

[5]  P. Goedegebuure,et al.  Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-γ , 1993, Cancer Immunology, Immunotherapy.

[6]  M. Herlyn,et al.  Melanoma cells and normal melanocytes share antigens recognized by HLA- A2-restricted cytotoxic T cell clones from melanoma patients , 1993, The Journal of experimental medicine.

[7]  T. Whiteside,et al.  T cell recognition of human tumors: implications for molecular immunotherapy of cancer. , 1993, Clinical immunology and immunopathology.

[8]  G. Nicolini,et al.  Expansion of Major Histocompatibility Complex-Restricted Antimelanoma Cytotoxic T-Cell Lymphocyte Clones with Identical T-Cell Receptor from Tumor-Infiltrating Lymphocytes , 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[9]  R. Kerbel,et al.  Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Hersey,et al.  MHC‐restricted responses of CD8+ AND CD4+ T‐cell clones from regional lymph nodes of melanoma patients , 1992, International journal of cancer.

[11]  T. Whiteside,et al.  Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. , 1991, Cancer research.

[12]  A. Sant,et al.  Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules. , 1991, Journal of immunology.

[13]  D. Morton,et al.  Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor. , 1991, Cancer research.

[14]  L. Steinman,et al.  Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma. , 1990, Science.

[15]  N. Chakraborty,et al.  T‐Cell Clones that react against Autologous Human Tumors , 1990, Immunological reviews.

[16]  A. Cochran,et al.  Lymphocyte subset alterations in nodes regional to human melanoma. , 1990, Cancer research.

[17]  T. Ottenhoff,et al.  Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man , 1990, The Journal of experimental medicine.

[18]  R. Kradin,et al.  Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies. , 1989, Journal of immunology.

[19]  N. Chakraborty,et al.  Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma , 1989, The Journal of experimental medicine.

[20]  S. Rosenberg,et al.  Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. , 1989, Journal of immunology.

[21]  P. Lipsky,et al.  Phenotypic and functional characterization of human T cell clones. , 1988, Journal of immunology.

[22]  S. Miescher,et al.  Proliferative and cytolytic potentials of purified human tumor‐infiltrating t lymphocytes. Impaired response to mitogen‐driven stimulation despite T‐cell receptor expression , 1988, International journal of cancer.

[23]  S. Miescher,et al.  Altered activation pathways in T lymphocytes infiltrating human solid tumors. , 1988, Transplantation proceedings.

[24]  M. Ferrarini,et al.  Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response , 1987, The Journal of experimental medicine.

[25]  E. Korn,et al.  Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans. , 1987, Cancer research.

[26]  A. Cochran,et al.  Suppressor cell activity in melanoma-draining lymph nodes. , 1987, Cancer research.

[27]  E. Korn,et al.  Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies. , 1987, Journal of the National Cancer Institute.

[28]  S. Miescher,et al.  Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. , 1986, Journal of immunology.

[29]  B. Fleischer.  Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture , 1984, Nature.

[30]  G. Pantaleo,et al.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity , 1983, The Journal of experimental medicine.

[31]  S. Ferrone,et al.  Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions , 2004, Cancer Immunology, Immunotherapy.

[32]  J C Briggs,et al.  Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.

[33]  T. Whiteside,et al.  Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy. , 1992, Critical reviews in oncology/hematology.

[34]  T. Whiteside,et al.  Tumor-infiltrating lymphocytes , 1992 .

[35]  T. Mosmann,et al.  Cytokine secretion phenotypes of TH cells: how many subsets, how much regulation? , 1991, Research in immunology.

[36]  R. Coffman,et al.  Leishmania major infection in mice: a model system for the study of CD4+ T-cell subset differentiation. , 1991, Research in immunology.

[37]  T. Whiteside,et al.  Characteristics of natural killer cells and lymphokine-activated killer cells : their role in the biology and treatment of human cancer , 1990 .